Identification of variants in genes associated with hypertrophic cardiomyopathy in Mexican patients
PMID 37498360
Gene: TPM1
HGNC ID: 12010
Identification of variants in genes associated with hypertrophic cardiomyopathy in Mexican patients
PMID 37498360
Gene: TPM1
HGNC ID: 12010
Identification of a novel missense mutation in the TPM1 gene via exome sequencing in a Chinese family with dilated cardiomyopathy
PMID: 35029218
Gene: TPM1
HGNC ID: 12010
The proband (II-1) was a 40-year-old Chinese Han male born at full term after an uncomplicated pregnancy and delivery.
Case#: Proband(II-1)
DiseaseAssertion: DCM1Y
FamilyInfo: Chinese Han family with DCM phenotypes.
ParentalTesting: not reported
CasePresentingHPOs: HP:0001644
CaseHPOFreeText: Proband diagnosed with dilated cardiomyopathy and found to carry a TPM1 variant.
CaseNotHPOs: not reported
CaseNotHPOFreeText: not reported
CasePreviousTesting: not reported
Genotyping Method: Next-generation sequencing (NGS), confirmed by Sanger sequencing
FunctionalAnalysis: none reported
Variant: TPM1 c.340G>C (p.E114Q) missense variant
ClinVar: not found
CAID: CA392721071
gnomAD:
AdditionalInfo:
A young girl, 11 years old, died suddenly without any specific trigger factor during her usual daily activities.
Case#: 11 year old girl
DiseaseAssertion: hypertrophic cardiomyopathy
FamilyInfo: unremarkable
ParentalTesting: Both parents were tested and neither carried the variant
CasePresentingHPOs: HP:0001639 HP:0011675
CaseHPOFreeText: Post-mortem examination revealed asymmetric non-obstructive hypertrophy of the interventricular septum.
CaseNotHPOs: Syncope absent
CaseNotHPOFreeText: No complaints, normal exercise tolerance, no syncope, no medications, and no significant family history.
CasePreviousTesting: Autopsy and sudden cardiac death investigation.
Genotyping Method: Genetic testing performed as part of post-mortem investigation; familial cascade screening.
FunctionalAnalysis:
Variant: TPM1 c.656A>T (p.Asp219Val, p.D219V)
ClinVar: absent
CAID: CA2998480361
gnomAD: absent
AdditionalInfo: Variant classified as likely pathogenic (Class IV) by the authors and determined to be de novo.
De Novo Asp219Val Mutation in Cardiac Tropomyosin Associated with Hypertrophic Cardiomyopathy
PMID: 36613463
Gene: TPM1
HGNC ID: 12010
Combinatorial interactions of genetic variants in human cardiomyopathy
PMID: 30923642
Gene: TPM1
HGNC ID: 12010
he proband initially presented with severe heart failure and required heart transplantation at age 14
Case#: Patient A
DiseaseAssertion: Dilated Cardiomyopathy (DCM)
FamilyInfo: Large multigenerational family with DCM. Six family members identified. TPM1 and VCL variants are connected to disease.
ParentalTesting: Both parents presented with DCM and TPM1 variant c.97G>A.[p.glu33Lys, p.E33K].
CasePresentingHPOs: HP:0001644 HP:0012664 HP:0001635
CaseHPOFreeText: severe heart failure and required heart transplant. Left ventricular ejection fraction.
CaseNotHPOs:unkown
CaseNotHPOFreeText: unkown
CasePreviousTesting: unkown
Genotyping Method: PCR amplification & Sanger sequencing.
FunctionalAnalysis: functional data support that TPM1 and VCL variants act synergistically to impact cardiomyocyte contractility and sarcomeric organization and suggest that together these variants may perturb sarcomeric–costameric interactions.
Variant: TPM1 c.97G>A (p.Glu33Lys; E33K)
ClinVar: not found
CAID: CA018447
gnomAD: not reported
AdditionalInfo:
Genetic Clues on Implantable Cardioverter-Defibrillator Placement in Young-Age Hypertrophic Cardiomyopathy: A Case Report of Novel MYH7 Mutation and Literature Review
PMID: 35004917
Gene: TPM1
HGNC ID: 12010
Genetic Variants Are Not Rare in ICD Candidates with Dilated Cardiomyopathy: Time for Next-Generation Sequencing?
PMID: 31179125
Gene: TPM1
HGNC ID: 12010
Patient 2
Case#: A 36-year-old Italian female
DiseaseAssertion: Restrictive cardiomyopathy (RCM), associated with a homozygous TPM1 p.Asn279His variant.
FamilyInfo: The patient’s parents are first cousins and confirmed heterozygotes for p.Asn279His (Fig 2).The patient’s 75-year-old father was diagnosed with HCM at 42 years of age. He reportedly has a history of heart failure but is currently asymptomatic. The patient’s 67-year-old mother had her first echocardiogram after the patient’s diagnosis.(Table I).
ParentalTesting: Father and mother
CasePresentingHPOs: HP:0100749, HP:0002875, HP:0002094, HP:0012764, HP:0003270, HP:0000131, HP:0001635
CaseHPOFreeText: She was diagnosed with RCM and is being evaluated for heart transplantation. was referred for chest pain, lightheadedness, shortness of breath, significant fatigue, dyspnea on exertion, three-pillow orthopnea and abdominal bloating. Eighteen months previously, she had been diagnosed with an unspecified form of cardiomyopathy after developing volume overload while hospitalized for a right oophorectomy and uterine fibroid removal. Her symptoms were consistent with NYHA III–IV heart failure. She has continued to have significant heart failure symptoms that have been difficult to control with medical therapy. Freedom from arrhythmias, however, has been notable. She is currently being considered for orthotopic heart transplantation but her evaluation has been complicated by psychiatric issues.
CaseNotHPOs: HP:0001279, HP:0010741
CaseNotHPOFreeText: She denied syncope and lower extremity edema
CasePreviousTesting: The patients father and mother were tested.
Genotyping Method: Sarcomere gene sequencing
FunctionalAnalysis: used computational analysis and evolutionary conservation to assess the variant of TPM1 p.Asn279His.
Variant: NM_001018005.2:c.835A>C
ClinVar: 43446
CAID: CA018397
gnomAD: NR
Mutation-Specific Phenotypes in hiPSC-Derived Cardiomyocytes Carrying Either Myosin-Binding Protein C Or α-Tropomyosin Mutation for Hypertrophic Cardiomyopathy
PMID: PMID:27057166
Gene: TPM1
Disease: hypertrophic cardiomyopathy 3
MonDO: MONDO:0007267
InheritancePattern: AD
The Ca2+handling properties of hiPSC-derived CMs were studied by Ca2+ imaging. HCMT-CMs had significantly more abnormalities than WT-CMs and HCMM-CMs, when all time points in each group were combined (Figure 2(d), n = 6 in statistical analysis, p < 0.05). Spontaneously beating CMs were divided into five different rhythm categories (normal, oscillation, low/middle peaks, double peaks, and plateau abnormality) based on the abnormalities observed in their Ca2+ signals (Figures 2(e) and 2(f)). HCMT-CMs had significantly higher number of double peaks than HCMM-CMs (p < 0.05, n = 6 in statistical analysis) when both cell lines and all time points were combined for each group
ExperimentName: Ojala 2016 hiPSC-derived CMs
PatientCell: CL_0002620 (skin fibroblasts)
GeneFunction: GO:0008016 (regulation of heart contraction)
GeneAlteration: hiPSC-derived cardiomyocytes (CMs) generated from skin fibroblasts collected from patients carrying a TPM1-Asp175Asn mutation
FunctionalEvidence: Figure 2 shows enlarged cardiomyocytes (CMs) (a-b), an increase in multinucleated CMs (c), and calcium handling abnormalities (d) for the HCM-TPM1 variant CMs compared to WT CMs.
FAVariants: NM_001018005.2(TPM1):c.523G>A (p.Asp175Asn), CA018106
the effect of the mutations was a small decrease (5%) in the maximum sliding speed in the presence of saturating calcium (Table)
ExperimentName: Karibe 2001 In vitro motility
NonPatientCell: mechanical actin-myosin functional assay
GeneFunction: GO:0030049 (muscle filament sliding)
GeneAlteration: PCR-based mutagenesis of Ala to Ser was used at nucleotide position 340 (GenBank M19713) to produce cDNA encoding the V95A variant. This coding sequence was inserted into the pET3d expression vector and the wild-type or mutant tropomoysin protein was expressed in DE3 cells before being purified to homogeneity for use in the in vitro assays.
FunctionalEvidence: Mutant tropomyosin-containing actin-troponin-tropomyosin filaments combined with rhodamine-phalloidin had slightly decreased (5%) sliding speed on a heavy meromyosin-coated surface compared to wild-type tropomyosin-containing filaments under saturating calcium conditions (Table 1).
FAVariants: NM_001018005.2(TPM1):c.284T>C (p.Val95Ala), CA017934
plified from DNA derived from affected individuals offamily MI. In addition to the guanine residue at nucleotideposition
Case#: Family MI, Northern European
CasePresentingHPOs: HP:0001639
CaseHPOFreeText:
CaseNotHPOs:
CaseNotHPOFreeText:
CasePreviousTesting:
CaseMethod1:
CaseMethod2:
CaseGenotypingMethod: PCR amplification followed by Cycle Sequencing
Variant: The nucleotide variant positions here refer to those described in the initial cloning of the gene in 1988 (PMID: 3336363), but nucleotide G579A here aligns to NM_001018005.2(TPM1):c.523G>A (p.Asp175Asn).
ClinVar: 12456
CAID: CA018106
gnomAD: Grpmax FAF = 7.900e-7, SNV: 15-63060899-G-A, gnomADv4_D175N
VariantEvidence:
CaseAddInfo:
CasePMIDs: PMID:8327508
nucleotide position 595 in exon 5 of the a-tropomyosingene (Figure 2, left). The normal adenine residue was alsoprese
Case#: Family MZ, Northern European
CasePresentingHPOs: HP:0001639 ( Hypertrophic cardiomyopathy)
CaseHPOFreeText:
CaseNotHPOs:
CaseNotHPOFreeText:
CasePreviousTesting:
CaseMethod1:
CaseMethod2:
CaseGenotypingMethod: PCR amplification followed by Cycle Sequencing
Variant: The nucleotide variant positions here refer to those described in the initial cloning of the gene in 1988 (PMID: 3336363), but nucleotide A595G here aligns to NM_001018005.2(TPM1):c.539A>G (p.Glu180Gly).
ClinVar: 12455
CAID: CA019017
gnomAD: 15-63060915-A-G not in gnomAD v4.0.0
VariantEvidence:
CaseAddInfo:
CasePMIDs: PMID:8327508
The aspartate-to-asparagine substitution in exon 5 of the α-tropomyosin gene (Asp175Asn, numbered according to Reference 15), which was previously identified in the proband, results from a guanine-to-adenine transition at nucleotide residue 579 (G579A)
Case#: Proband_DBIII-2, 53 y.o., M
CasePresentingHPOs: HP:0001712
CaseHPOFreeText: Max LVWT 18 mm; LA size 40 mm; episode of sustained VT
CaseNotHPOs:
CaseNotHPOFreeText:
CasePreviousTesting: None
CaseMethod1: PCR amplification of TPM1 exon 5 followed by cycle sequencing
CaseMethod2: STR polymorphisms to construct haplotypes
CaseGenotypingMethod: PCR amplification of TPM1 exon 5 followed by cycle sequencing
Variant: The nucleotide position 579 refers to that described in the initial cloning of the gene in 1988 (PMID: 3336363), but aligns to NM_001018005.2(TPM1):c.523G>A (p.Asp175Asn).
ClinVar: ClinVar:12456
CAID: CA018106
gnomAD: Grpmax FAF = 7.900e-7, SNV: 15-63060899-G-A, gnomADv4_D175N
CasePMIDs:
echocardiographic screening of her immediate family revealed that her father and 2 of 3 siblings had cardiac hypertrophy
FamilyLabel: Van Driest Family
Family#PresentingHPOs: HP:0001639 (hypertrophic cardiomyopathy)
FamilyNotHPOs:
CountryOrigin:
Ethnicity:
Race:
Family#PreviousTesting: Three highly polymorphic markers for each of 9 known HC genes (MYH7, TNNT2, TNNI, TPM1, MYL3, MYL2, MBPC, ACTC, and PRKAG2) were PCR-amplified for haplotype analysis. Only 3 candidate genes, MYL3, TNNT2, and TPM1, were shared by proband, affected siblings, and father.
Family#Method1: (other) PCR amplification of all protein-coding exons and splice junctions of the 3 candidate genes from genomic DNA was analyzed using DHPLC (denaturing high-performance liquid chromatography).
Family#Method2: Cycle sequencing was performed on all DHPLC amplicons with abnormal elution profiles (exon 5 of TPM1).
Family#GenotypingMethod: DHPLC screening followed by cycle sequencing of TPM1 exon 5.
Affected: 4
Unaffected:
Segregations: 3 (Figure 1)
PublishedLOD: N/A
eLOD: N/A; < 4 segregations
AddSegregationInfo:
ProbandLabel: III-1
Variant: NM_001018005.2(TPM1):c.554T>G (p.Leu185Arg)
ClinVar: 31881
CAID: CA019057
gnomAD: 15-63060930-T-G has no data in gnomAD v4.0.0
FamilyAddInfo: TPM1 variant reported as c.T610G (p.L185R), using coding positions relative to GeneBank accession M19713.1?
FamilyPMIDs:
The proband was an 8-year-old female who died suddenly in 1997. Autopsy revealed signs of cardiac hypertrophy
Case#: III-1
CasePresentingHPOs: HP:0001639 (hypertrophic cardiomyopathy); HP:0001645 (sudden cardiac death)
CaseHPOFreeText:
CaseNotHPOs:
CaseNotHPOFreeText:
CasePreviousTesting: None for the proband
CaseMethod1:
CaseMethod2:
CaseGenotypingMethod: DNA extracted from paraffin-embedded spleen tissue, taken at autopsy, was subjected to PCR-amplification of TPM1 exon 5 followed by cycle sequencing to confirm presence of the familial TPM1 variant.
Variant: NM_001018005.2(TPM1):c.554T>G (p.Leu185Arg)
ClinVar: 31881
CAID: CA019057
gnomAD: 15-63060930-T-G has no data in gnomAD v4.0.0
VariantEvidence: Chang, et al. 2005 (PMID:16043485) demonstrated in ATPase activity assays that myofibrils reconstituted with L185R mutant tropomyosin had an increased sensitivity to calcium compared to wild-type tropomyosin-reconstituted myofibrils.
CaseAddInfo: No other genes were screened for mutations in this proband.
CasePMIDs:
Functional Consequences of Hypertrophic and Dilated Cardiomyopathy-causing Mutations in α-Tropomyosin*
PMID: PMID:16043485
Gene: TPM1
Disease: hypertrophic cardiomyopathy 3
MonDO: MONDO:0007267
InheritancePattern: AD